TAT and infection: Pre-challenge anti-Tat IgG1 titers correlated with the rate of plasma viremia reduction in the post-acute phase of infection (r = −0.8 p = 0.0086 at week 8 and r = −0.7 p = 0.021 at weeks 16 and 22) (Fig. 7C).